Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002649 |
---|---|
Receipt number | R000003226 |
Scientific Title | Phase I/II study of preoperative chemoradiotherapy with Gemcitabine and S-1 for resectable pancreatic cancer |
Date of disclosure of the study information | 2009/10/19 |
Last modified on | 2020/04/27 09:14:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/10/19 23:38:17 | ||
2 | Update | 2013/10/20 08:57:03 | Last follow-up date |
|
3 | Update | 2013/10/20 09:01:54 | Email Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2014/12/23 15:14:43 | UMIN ID1 |
|
5 | Update | 2015/04/28 20:04:29 | Last name of lead principal investigator Last name of lead principal investigator |
|
6 | Update | 2016/04/19 09:56:23 | Recruitment status Last follow-up date |
|
7 | Update | 2018/04/26 16:22:12 | Name of primary person or sponsor Organization Organization |
|
8 | Update | 2020/04/27 09:10:49 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
9 | Update | 2020/04/27 09:11:14 | Number of participants that the trial has enrolled |
|
10 | Update | 2020/04/27 09:12:09 | Date of IRB |
|
11 | Update | 2020/04/27 09:12:34 | Recruitment status |
|
12 | Update | 2020/04/27 09:13:38 | Date of closure to data entry |
|
13 | Update | 2020/04/27 09:14:19 | Date trial data considered complete Date analysis concluded |